Are outdated microbial identification methods risking your product safety and operational efficiency?
Join this webinar to unravel the complexities of microbial identification technologies and their pivotal role in fortifying contamination control strategies within the pharmaceutical industry.
Pharma Horizons: Environmental Monitoring
By European Pharmaceutical Review
FDA approval could shape liver disease treatment landscape
By Catherine Eckford (European Pharmaceutical Review)
Developing a new treatment paradigm for IgAN
By Catherine Eckford (European Pharmaceutical Review), Dr Marshall Fordyce (Vera…
Boehringer collaboration could advance first-in-class schizophrenia treatments
By Catherine Eckford (European Pharmaceutical Review)
Validation of analytical procedures – ICH Q2(R2)
By Dave Elder (JPAG Member and David P Elder Consultancy)
Developing a new treatment paradigm for IgAN
By Catherine Eckford (European Pharmaceutical Review), Dr Marshall Fordyce (Vera…